2013
DOI: 10.1007/s00775-013-1003-7
|View full text |Cite
|
Sign up to set email alerts
|

Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells

Abstract: The cisplatin analogues cis-[PtCl2(3ClHaza)2] (1) and cis-[PtCl2(3IHaza)2] (2) (3ClHaza and 3IHaza are 3-chloro-7-azaindole and 3-iodo-7-azaindole, respectively) are quite toxic to ovarian tumor cells, with moderately better IC50 values than for cisplatin in the cisplatin-sensitive cell line A2780. We investigated potential factors which might be involved in the mechanism underlying the cytotoxic effects of 1 and 2 and compared these factors with those involved in the mechanism underlying the effects of conven… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 40 publications
1
12
2
Order By: Relevance
“…Treatment by complexes 6 and 8 led to the cell cycle perturbations different from recently reported cis - and trans -platinum(II) diiodido complexes [10] as well as from mixed-ligand platinum(II) dichlorido complexes containing 7-azaindole-based N -donor ligand [6], whose application resulted in higher S cell cycle phase populations. Only the low portion of populations (1.2–4.3%) corresponding to apoptotic and necrotic cells were identified in the sub-G1 region after 24 h exposure to complexes 6 and 8 (Fig 4), which is considerably different than recently reported for dichlorido analogues (sub-G1 populations of ca 30%) of the herein studied platinum(II) diiodido complexes [43]. Cisplatin , on the other hand, showed a typical increase of the S cell cycle phase populations in both the cancer cell lines [6,10,42,43], resulting in higher S and lower G0/G1 populations than observed for complexes 6 and 8 (and control cells) on both MCF-7 and A2780 cancer cells (Fig 4).…”
Section: Resultscontrasting
confidence: 74%
See 1 more Smart Citation
“…Treatment by complexes 6 and 8 led to the cell cycle perturbations different from recently reported cis - and trans -platinum(II) diiodido complexes [10] as well as from mixed-ligand platinum(II) dichlorido complexes containing 7-azaindole-based N -donor ligand [6], whose application resulted in higher S cell cycle phase populations. Only the low portion of populations (1.2–4.3%) corresponding to apoptotic and necrotic cells were identified in the sub-G1 region after 24 h exposure to complexes 6 and 8 (Fig 4), which is considerably different than recently reported for dichlorido analogues (sub-G1 populations of ca 30%) of the herein studied platinum(II) diiodido complexes [43]. Cisplatin , on the other hand, showed a typical increase of the S cell cycle phase populations in both the cancer cell lines [6,10,42,43], resulting in higher S and lower G0/G1 populations than observed for complexes 6 and 8 (and control cells) on both MCF-7 and A2780 cancer cells (Fig 4).…”
Section: Resultscontrasting
confidence: 74%
“…Only the low portion of populations (1.2–4.3%) corresponding to apoptotic and necrotic cells were identified in the sub-G1 region after 24 h exposure to complexes 6 and 8 (Fig 4), which is considerably different than recently reported for dichlorido analogues (sub-G1 populations of ca 30%) of the herein studied platinum(II) diiodido complexes [43]. Cisplatin , on the other hand, showed a typical increase of the S cell cycle phase populations in both the cancer cell lines [6,10,42,43], resulting in higher S and lower G0/G1 populations than observed for complexes 6 and 8 (and control cells) on both MCF-7 and A2780 cancer cells (Fig 4). Taken together, application of complexes 6 and 8 led to the cell cycle perturbations indirectly indicating different mechanism of action from cisplatin .…”
Section: Resultscontrasting
confidence: 74%
“…Consequently, the G 0 /G 1 population decreased for 1 and 5 as compared with the control cells, while the number of cells in the S cell cycle phase was comparable for 1 and 5 , and the non-treated control cells. Different modification of the A2780 cell cycle, induced by the studied gold(I) complexes (i.e., G 2 -arrest) and cisplatin (i.e., S-arrest), is indicative for different mechanism of anticancer action of 1 and 5 , as compared with conventional cisplatin [47]. The mentioned G 2 -arrest observed at the A2780 cells treated by the complexes 1 and 5 is different from the cell cycle modification provoked by different gold(I) complexes including auranofin .…”
Section: Discussionmentioning
confidence: 99%
“…13, the hydrogen atoms were located using the rigid model with the fixed C-H bond lengths (0.95 Å) and the identical values of the H n -C-N and H n -C-C angles (n=2, 3,4,6). In our study, the coordinates and isotropic displacement parameters of all hydrogen atoms were refined freely.…”
Section: Description Of the Crystal And Molecular Structure Of 5br7aimentioning
confidence: 99%
“…These compounds have revealed the antiproliferative [1], anticancer [2][3][4][5] and anti-inflammatory [6] activities. They also act as protein kinase inhibitors in the treatment of kinase induced diseases [7,8].…”
Section: Introductionmentioning
confidence: 99%